Skin Cancer is one of the leading causes of death across Australia and New Zealand, and 2 in 3 people are diagnosed with skin cancer by the age of 70. (Cancer Council Australia, 2019).
Added to this data, it has also been found that 61% of the same populations feel that having tanned skin is attractive, and only 11% have their skin checked at least once per year. (‘2020 Melanoma Skin Cancer Report: Stemming the Global Epidemic’ Report).
Reports and data has shown a significant drop-off in routine testing during COVID-19, including analysing tissue samples for cancer diagnoses. (Experts call for urgent attention on melanoma screening and checks in light of deadly delays in testing with COVID-19. Science & Medical | 11/05/2020)
COVID-19 limitations and added challenges
The population, including employees that would normally have access to onsite skin cancer checks in the workplace, are currently avoiding regular skin cancer detection.
Many employees are working from home, reducing the number of onsite skin cancer checks in the workplace. Reports also show a drop in presentation to medical centres for routine GP check ups employees (and the general population) must have options to review and assess any moles or sunspots of concern at a minimum.